CRISPR screens are feasible in TP53 wild-type cells
Related Experiment Video
Updated: Jan 20, 2026

Pooled CRISPR-Based Genetic Screens in Mammalian Cells
Published on: September 4, 2019
Kevin R Brown1, Barbara Mair1, Martin Soste1
1Donnelly Centre, University of Toronto, Toronto, ON, Canada.
Abstract:
A recent study by Haapaniemi et al (2018) reported that intact p53 signaling hampers CRISPR-based functional genomic screens. Brown et al report good performance of genome-scale screens in TP53 wild-type cells and reiterate best practices for CRISPR screening.
Related Concept Videos
09:05Pooled CRISPR-Based Genetic Screens in Mammalian Cells
08:49Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens
05:11Wild-Type Blocking PCR to Detect Low-Frequency Somatic Mutations
07:37Performing an In Vitro Genome-Wide CRISPR Knockout Screen in Chimeric Antigen Receptor T Cells
Phenotypic Comparison of Wild-Type and Mutant Strains of Streptomyces coelicolor
Transfection of Wild-Type Amoeba via Electroporation with Bacterial Feeding Support

